4502:TYO
Takeda Pharmaceutical Company
6.673,00 JPY
arrow_upward
+1,21%(+80,00) 1D
11. stu, 15:30:00 GMT+9 · JPY
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 4502...
Otvori
6.693 JPY
Najviša
6.759 JPY
Najniža
6.611 JPY
Trž. kap.
10,69 bil.
Prosj. kol.
4,86 mil.
Količina
4,38 mil.
Dividenda
3,03 %
Kvartalna dividenda
50 JPY
Datum nakon isplate dividende
29. ruj 2026.
P/E omjer
318,68
52-tjed. najviša
6.989 JPY
52-tjed. najniža
4.191 JPY
EPS
21 JPY
Dionice u optjecaju
784,48 mil.
Broj djelatnika
47 tis.
Otvori
6.693 JPY
Najviša
6.759 JPY
Najniža
6.611 JPY
Trž. kap.
10,69 bil.
Prosj. kol.
4,86 mil.
Količina
4,38 mil.
Dividenda
3,03 %
Kvartalna dividenda
50 JPY
Datum nakon isplate dividende
29. ruj 2026.
P/E omjer
318,68
52-tjed. najviša
6.989 JPY
52-tjed. najniža
4.191 JPY
EPS
21 JPY
Dionice u optjecaju
784,48 mil.
Broj djelatnika
47 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Naslovi.net
·
prije 1 dan
Wall Street: Uzlet indeksa, tehnološki sektor opet raste
markets.businessinsider.com
·
prije 11 minuta
Rantizo (Nasdaq: RNTZ) Advances U.S. Production of Heavy-Lift Autonomous Drones After $258.8 Million Acquisition, Targets California’s $61.2 Billion Agricultural Market
Barchart.com
·
prije 51 minutu
Nasdaq Futures Rally as CoreWeave and Anthropic Fuel AI Optimism
Reuters
·
prije 2 sata
Mapping the Market: S&P 500 at risk of further losses
Profil
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Takeda Pharmaceutical Company – informacije
Glavni izvršni direktorChristophe Weber | Christophe Weber
Zaposlenici47 tis.
Osnovano12. lip 1781.
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijatakeda.com